Novel Treatment of Small-Cell Neuroendocrine of the Vagina
Background. Primary vaginal small-cell neuroendocrine carcinoma is an extremely rare and highly aggressive malignancy. Eighty-five percent of patients die within one year of diagnosis from metastatic disease despite multimodal therapy. Gene expression profiling of tumor tissue may be useful for trea...
Saved in:
Main Authors: | Kathryn Kostamo, Mishka Peart, Nathalie McKenzie, Conisha Holloman, S. J. Carlan, Li Ge, John Maksem |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2018/9157036 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primary Small Cell Carcinoma of the Vagina
by: Rafael Oliveira, et al.
Published: (2013-01-01) -
Small Pancreas Neuroendocrine Tumors: How Small is Small?
by: Ming-Huang Chen, et al.
Published: (2023-04-01) -
Primary T-Cell Non-Hodgkin Lymphoma of the Vagina
by: J. L. Herraiz, et al.
Published: (2015-01-01) -
Müllerian Cyst of the Vagina Masquerading as a Cystocele
by: Emrah Töz, et al.
Published: (2015-01-01) -
The biomechanics of the vagina: a complete review of incomplete data
by: Justin Dubik, et al.
Published: (2025-01-01)